BiBBInstruments announces that researchers at Mayo Clinic in Jacksonville presented promising results with EndoDrill GI for tissue sampling in pancreatic cancer. The study included three patients with PDAC tumors where EndoDrill GI showed the potential to yield high-quality tissue cores with reduced blood contamination compared to standard needles. The researchers are now planning a larger study to confirm reproducibility and potentially establish EndoDrill GI as a new standard technique for tissue culture research.
|
Published September 9, 2025
BibbInstruments announces promising results from Mayo Clinic
Notes
Johnson & Johnson acquires Halda Therapeutics for $3 billion
Magle Group submits application for EmboCept S
Quia Pharma is delisted from Nasdaq
Stenocare acquires CannGros
Lundbeck enters the fight for Avadel
Klaria's partner CNX starts production of migraine film
Sofinnova Partners raises EUR 650 million in new fund
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account